A'Hern R - Search Results

1

Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?

Marsden J, Whitehead M, A'Hern R, Baum M, Sacks N. Marsden J, et al. Fertil Steril. 2000 Feb;73(2):292-9. doi: 10.1016/s0015-0282(99)00510-5. Fertil Steril. 2000. PMID: 10685532 Free article. Clinical Trial.

2

Progestogens and breast cancer risk: the role of hormonal contraceptives and hormone replacement therapy.

Marsden J, A'Hern R. Marsden J, et al. J Fam Plann Reprod Health Care. 2003 Oct;29(4):185-7. doi: 10.1783/147118903101198042. J Fam Plann Reprod Health Care. 2003. PMID: 14662049 Free article. Review. No abstract available.

3

Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosages and two administration systems.

Ebbs SR, Saunders JA, Graham H, A'Hern RP, Bates T, Baum M. Ebbs SR, et al. Acta Oncol. 1989;28(6):887-92. doi: 10.3109/02841868909092326. Acta Oncol. 1989. PMID: 2692652 Clinical Trial.

4

The Cancer Research Campaign trials of adjuvant therapy for early breast cancer.

Baum M, Ebbs SR, Houghton J, A'Hern RP, Riley D. Baum M, et al. Acta Oncol. 1989;28(6):907-12. doi: 10.3109/02841868909092330. Acta Oncol. 1989. PMID: 2692654 Clinical Trial.

5

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

Dowsett M, Houghton J, Iden C, Salter J, Farndon J, A'Hern R, Sainsbury R, Baum M. Dowsett M, et al. Ann Oncol. 2006 May;17(5):818-26. doi: 10.1093/annonc/mdl016. Epub 2006 Feb 23. Ann Oncol. 2006. PMID: 16497822 Free article. Clinical Trial.

6

Using an interactive video disk in breast cancer patient support.

Maslin AM, Baum M, Walker JS, A'Hern R, Prouse A. Maslin AM, et al. Nurs Times. 1998 Nov 4-10;94(44):52-5. Nurs Times. 1998. PMID: 9919256 Clinical Trial.

7

The Million Women Study and breast cancer.

Marsden J, A'Hern R. Marsden J, et al. J Br Menopause Soc. 2003 Sep;9(3):95, 97. doi: 10.1177/136218070300900302. J Br Menopause Soc. 2003. PMID: 14670192 No abstract available.

8

More breast cancer findings from the Women's Health Initiative.

Marsden J, A'Hern R, whitehead M. Marsden J, et al. J Br Menopause Soc. 2003 Sep;9(3):97-9. doi: 10.1177/136218070300900303. J Br Menopause Soc. 2003. PMID: 14959718 No abstract available.

9

Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.

Harper-Wynne CL, Sacks NP, Shenton K, MacNeill FA, Sauven P, Laidlaw IJ, Rayter Z, Miall S, Howes A, Salter J, Hills MJ, Lowe FM, A'Hern R, Nasiri N, Doody D, Iqbal J, Dowsett M. Harper-Wynne CL, et al. J Clin Oncol. 2002 Feb 15;20(4):1026-35. doi: 10.1200/JCO.2002.20.4.1026. J Clin Oncol. 2002. PMID: 11844826 Clinical Trial.

10

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M. Harper-Wynne C, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):614-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101108 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters